Russell Kevin Klass, Senior Vice President of Sales at Zomedica Corp. (ZOM), bought 699,980 shares at $0.07 ($49K) on 2025-03-17, disclosed to the SEC on 2025-03-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| ZOMDF | BUY | 2025-11-14 | $15K | — | Filing → |
| ZOMDF | BUY | 2025-11-12 | $12K | — | Filing → |
| ZOMDF | BUY | 2025-11-10 | $500 | — | Filing → |